•  
  •  
  •  
  •  

2026-07-19 15:37:29

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • LTM Partners with Glean to Accelerate Enterprise AI Adoption
  • Rajesh Power Services Ltd receives orders from PGVCL
  • Muthoot Capital Services Q1 FY27 Results: Net Profit Surges 51.4% Sequentially to ₹812.21 Lakhs, Turning Profitable Year-on-Year
  • PNB Gilts Q1 FY27 Results: Net Profit Surges Over 500% Sequentially to ₹8,069.80 Lakhs, Driven by Strong Operating Performance
  • WeWork India Management Limited Q1 FY27 Results: Revenue Rises 27.7% YoY to ₹6,838.32 Million; Narrower Losses Driven by High Lease/Finance Overheads

Keywords Selected:  ConcordBiotech

IPO News

  • Concord Biotech Limited's IPO to open on Friday, 4th August, 2023, sets price band at ₹705 to ₹741 per Equity Share
  • Ahmedabad-based Concord Biotech gets SEBI nod for IPO
  • Rare Enterprises and Quadria Capital-backed Concord Biotech files DRHP for IPO

Stock Report

  • Concord Biotech Ltd successfully completes PPB and NDA inspection
  • Concord Biotech Ltd completes ANVISA Inspection conducted by the Brazilian Health Regulatory Agency at the Limbasi API Manufacturing Facility
  • Concord Biotech Ltd receives ANDA approval for Tofacitinib Tablets, 5 mg and 10 mg
  • Concord Biotech Ltd receives ANDA approval from USFDA for Mycophenolate Mofetil for Oral Suspension USP
  • Concord Biotech Ltd completes NAFDAC inspection successfully
  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Concord Biotech Ltd successfully completes Russian GMP insepction at its API facility
  • Concord Biotech Ltd announces successful completion EU GMP inspection at its API facility
  • Concord Biotech Limited receives EIR from USFDA for API facility at Dholka
  • USFDA Inspection at Concord Biotech Ltd's API facility at Dholka
  • Concord Biotech Limited receives final approval from USFDA for Teriflunomide Tablets
  • Concord Biotech Limited commences production of injectable at new facility
  • Ministry of Food and Drug Safety completes inspection at Concord Biotech's Dholka unit
  • Concord Biotech Limited gets EUGMP Certificate for Valthera Facility
  • Concord Biotech Limited receives EUGMP certificate for Dholka facility
  • ANVISA issues CGMP to Concord Biotech Ltd's Unit I
  • Concord Biotech Ltd receives GMP certificate from Kenya regulator
  • Concord Biotech Limited receives EIR for Unit III
  • Concord Biotech makes a healthy debut on the exchange, shares close 27% premium over the issue price

Latest Post

  • LTM Partners with Glean to Accelerate Enterprise AI Adoption
  • Rajesh Power Services Ltd receives orders from PGVCL
  • Muthoot Capital Services Q1 FY27 Results: Net Profit Surges 51.4% Sequentially to ₹812.21 Lakhs, Turning Profitable Year-on-Year
  • PNB Gilts Q1 FY27 Results: Net Profit Surges Over 500% Sequentially to ₹8,069.80 Lakhs, Driven by Strong Operating Performance
  • WeWork India Management Limited Q1 FY27 Results: Revenue Rises 27.7% YoY to ₹6,838.32 Million; Narrower Losses Driven by High Lease/Finance Overheads


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025